investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Nuclear Architecture and Disease

Tom Misteli

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Stephan Mathas

Charité

Berlin, Germany

Angus Lamond

University of Dundee

Dundee, United Kingdom

Tom Misteli

National Cancer Institute (NIH)

Rockville, United States

Related projects

Hannah Wang

Understanding the HSF1 pathway and its potential for cancer therapy

All cancers but non-melanoma skin cancer

Birge Raymond B

Non-canonical Signal Pathway for Crk in Breast Cancer

All cancers but non-melanoma skin cancer

Karmella Ann Haynes

Synthetic chromatin for cancer research

All cancers but non-melanoma skin cancer

Wu-Min Deng

Intercellular Communication and Oocyte Polarity

All cancers but non-melanoma skin cancer

Pathology

Michael Bustin

Chromosomal Proteins and Chromosomal Functions

All cancers but non-melanoma skin cancer

Eileen P. White

Identification of Metabolic Vulnerabilities of Ras-Driven Cancer Cells

All cancers but non-melanoma skin cancer

Margo G Haygood

Diverse Drug Lead Compounds from Bacterial Symbionts in Philippine Mollusks

All cancers but non-melanoma skin cancer

Mikhail Kashlev

Mechanism of the initial steps in transcription-coupled DNA repair (TCR)

All cancers but non-melanoma skin cancer

Dean W Felsher

Modeling and Predicting Therapeutic Resistance of Cancer

All cancers but non-melanoma skin cancer